Trademark: 90020292
Status Date
Monday, April 25, 2022
Filing Date
Thursday, June 25, 2020
Published for Opposition
Tuesday, January 26, 2021
Abandoned Date
Monday, April 25, 2022
5 pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of neurological diseases and disorders, central nervous system diseases and disorders, neurodegenerative diseases and disorders, immune system-related diseases and disorders, and metabolic diseases and disorders
42 research and development of pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of neurological diseases and disorders, central nervous system diseases and disorders, neurodegenerative diseases and disorders, immune system-related diseases and disorders, and metabolic diseases and disorders; pharmaceutical research and development
Apr 25, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 25, 2022
Abandonment - No Use Statement Filed
Jan 19, 2022
Automatic Update Of Assignment Of Ownership
Sep 24, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 22, 2021
Sou Extension 1 Granted
Sep 22, 2021
Sou Extension 1 Filed
Sep 22, 2021
Teas Extension Received
Mar 23, 2021
Noa E-Mailed - Sou Required From Applicant
Jan 26, 2021
Official Gazette Publication Confirmation E-Mailed
Jan 26, 2021
Published For Opposition
Jan 6, 2021
Notification Of Notice Of Publication E-Mailed
Dec 18, 2020
Approved For Pub - Principal Register
Dec 17, 2020
Teas/Email Correspondence Entered
Dec 16, 2020
Correspondence Received In Law Office
Dec 16, 2020
Teas Response To Office Action Received
Nov 4, 2020
Automatic Update Of Assignment Of Ownership
Sep 29, 2020
Notification Of Non-Final Action E-Mailed
Sep 29, 2020
Non-Final Action E-Mailed
Sep 29, 2020
Non-Final Action Written
Sep 28, 2020
Assigned To Examiner
Aug 4, 2020
New Application Office Supplied Data Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
